Cargando…

Treatment patterns and clinical outcomes for patients with melanoma and central nervous system metastases: A real‐world study

BACKGROUND: Patients with melanoma and central nervous system (CNS) metastases have poor survival outcomes. We investigated real‐world treatment patterns and overall survival (OS) of patients with melanoma and CNS metastases. METHODS: A retrospective analysis utilizing a nationwide de‐identified ele...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tawbi, Hussein, To, Tu My, Bartley, Karen, Sadetsky, Natalia, Burton, Elizabeth, Haydu, Lauren, McKenna, Edward
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704162/ https://www.ncbi.nlm.nih.gov/pubmed/34874127 http://dx.doi.org/10.1002/cam4.4438

Ejemplares similares

Economic and health care resource utilization burden of central nervous system metastases in patients with metastatic melanoma
por: Tawbi, Hussein, et al.
Publicado: (2022)

Survival outcomes in an older US population with advanced melanoma and central nervous system metastases: SEER‐Medicare analysis
por: Sadetsky, Natalia, et al.
Publicado: (2020)

OTHR-08. PREDICTION OF RISK OF CENTRAL NERVOUS SYSTEM METASTASIS FOR AJCC 8(TH) EDITION STAGE III MELANOMA PATIENTS
por: Haydu, Lauren, et al.
Publicado: (2019)

Real world outcomes of combination and timing of immunotherapy with radiotherapy for melanoma with brain metastases
por: Moyers, Justin T., et al.
Publicado: (2021)

Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities
por: Karz, Alcida, et al.
Publicado: (2022)

The efficacy of anti‐programmed cell death protein 1 therapy among patients with metastatic acral and metastatic mucosal melanoma
por: Ogata, Dai, et al.
Publicado: (2021)

Umbilical metastases: Real‐world data shows abysmal outcome
por: Hugen, Niek, et al.
Publicado: (2021)

Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarker
por: Fischer, Grant M., et al.
Publicado: (2020)

Treatment patterns and outcomes in BRAF V600E-mutant melanoma patients with brain metastases receiving vemurafenib in the real-world setting
por: Gibney, Geoffrey T, et al.
Publicado: (2015)

SDPS-37 IDENTIFICATION OF TIME-COURSE RELATED, TREATMENT-RELATED, AND PATIENT-RELATED PROGNOSTIC FACTORS IN BRAF-MUTANT MELANOMA BRAIN METASTASES.
por: Erickson, Lily G, et al.
Publicado: (2023)

Prognostic value of miR-21 for prostate cancer: a systematic review and meta-analysis
por: Stafford, M.Y. Cynthia, et al.
Publicado: (2022)

Multiple metastases in central nervous system and subdural hematoma in the course of melanoma
por: Woźniak-Dąbrowska, Kamila, et al.
Publicado: (2022)

Real‐world outcomes of advanced melanoma patients not represented in phase III trials
por: van Zeijl, Michiel C. T., et al.
Publicado: (2020)

Real-world evidence for option value in metastatic melanoma
por: Wong, William B, et al.
Publicado: (2021)

Targeted therapy in melanoma
por: Tawbi, Hussein, et al.
Publicado: (2009)

Emergent immunotherapy approaches for brain metastases
por: Wang, Jianbo, et al.
Publicado: (2021)

Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery
por: Tazi, Karim, et al.
Publicado: (2015)

Ipilimumab and radiation therapy for melanoma brain metastases
por: Silk, Ann W, et al.
Publicado: (2013)

Changes in outcomes and factors associated with survival in melanoma patients with brain metastases
por: Hasanov, Merve, et al.
Publicado: (2022)

Comprehensive analysis of cutaneous and uveal melanoma liver metastases
por: Hoefsmit, Esmee P, et al.
Publicado: (2020)

Hippocampal avoidance with volumetric modulated arc therapy in melanoma brain metastases – the first Australian experience
por: Awad, Raef, et al.
Publicado: (2013)

Extrinsic factors can mediate resistance to BRAF inhibition in central nervous system melanoma metastases
por: Seifert, Heike, et al.
Publicado: (2015)

Real‐world treatment practice in patients with advanced melanoma in the era before ipilimumab: results from the IMAGE study
por: Middleton, Mark R., et al.
Publicado: (2016)

Incidence and survival of childhood central nervous system tumors in Denmark, 1997–2019
por: Helligsoe, Anne Sophie Lind, et al.
Publicado: (2021)

Predictive value of a nomogram for melanomas with brain metastases at initial diagnosis
por: Liu, Hong, et al.
Publicado: (2019)

Uterine leiomyosarcoma with central nervous system metastases
por: Abrahão, Carina Meira, et al.
Publicado: (2015)

Cytokine Landscape in Central Nervous System Metastases
por: Marin, Julie, et al.
Publicado: (2022)

Real-world experience with elective discontinuation of PD-1 inhibitors at 1 year in patients with metastatic melanoma
por: Pokorny, Rebecca, et al.
Publicado: (2021)

Risk of somatic diseases in offspring of survivors with childhood or adolescent central nervous system tumor in Sweden
por: Huang, Wuqing, et al.
Publicado: (2020)

High frequency of brain metastases after adjuvant therapy for high‐risk melanoma
por: Samlowski, Wolfram E., et al.
Publicado: (2017)

Focal radiation necrosis of the brain in patients with melanoma brain metastases treated with pembrolizumab
por: Du Four, Stephanie, et al.
Publicado: (2018)

Mechanistic Modeling of Central Nervous System Pharmacokinetics and Target Engagement of HER2 Tyrosine Kinase Inhibitors to Inform Treatment of Breast Cancer Brain Metastases
por: Li, Jing, et al.
Publicado: (2022)

Bilateral pleural metastases of a primary central nervous system neuroblastoma in an adult: First case in the world
por: Loued, Lobna, et al.
Publicado: (2021)

Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial
por: Hurvitz, Sara A., et al.
Publicado: (2021)

Leptomeningeal metastases from a primary central nervous system melanoma: a case report and literature review
por: Pan, Zhenyu, et al.
Publicado: (2014)

Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases
por: Niessner, Heike, et al.
Publicado: (2013)

Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible
por: Fogarty, Gerald B, et al.
Publicado: (2014)

Leptomeningeal metastases in patients with human epidermal growth factor receptor 2 positive breast cancer: Real‐world data from a multicentric European cohort
por: Ratosa, Ivica, et al.
Publicado: (2022)

Surface antigen profiles of leukocytes and melanoma cells in lymph node metastases are associated with survival in AJCC stage III melanoma patients
por: Kaufman, Kimberley L., et al.
Publicado: (2014)

Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: A case series
por: Holbrook, Kourtney, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rqqhovl3bmd57p1fohjtt7h7b1